Titles A-Z

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z - 0-9

open this document and view its contentView the PDF document
Title: Impact of Public-Private Partnerships Addressing Access to Pharmaceuticals in Low and Middle Income Countries: Botswana
Themes: Tools for enhancing health equity
Authors: Druce, Nel; Kgatlwane, Joyce; Mosime, Otsetswe; Ramiah, Ilavenil
Keywords: access, Botswana, collaboration, drugs, impact, low- and middle-income countries, operational issues, pharmaceuticals, poverty
Year: 2004 Pages: 54
Abstract:
This study of public Private partnerships(PPPs) in Botswana for improving access to HIV/AIDS related pharmaceuticals is one of a series commissioned in 2003-2004 by the Initiative for Public-Private Partnerships for Health (IPPPH), and funded by the UK Department for International Development (DFID)

The study looked at PPPs to improve access to drugs for HIV/AIDS and related conditions, in contrast to the other countries, where PPPs also address to tropical diseases not prevalent in Botswana.
ISBN: 2-940286-24-8
open this document and view its contentView the PDF document
Title: Impact of Public-Private Partnerships Addressing Access to Pharmaceuticals in Low and Middle Income Countries: Sri Lanka
Themes: Tools for enhancing health equity
Authors: Abeykoon, Palitha; Caines, Karen
Keywords: access, collaboration, drugs, low- and middle-income countries, operational issues, pharmaceuticals, poverty, Sri Lanka
Year: 2004 Pages: 45
Abstract:
The UK Department for International Development (DFID) has funded the Initiative on Public-Private Partnership for Health (IPPPH) in association with the Institute for Health Sector Development, to conduct a country study in Sri Lanka, to access the health and health systems impact of public-private partnership for improving access to pharmaceuticals.
This study in Sri Lanka examined Novartis' donation of multi-drug therapy (MDT) for individual treatment of leprosy patients, and GlaxoSmithKline's (GSK) donation of albendazole for community mass drug administration to break the transmission of lymphatic filariasis (LF).
ISBN: 2-940286-24-X
open this document and view its contentView the PDF document
Title: Impact of Public-Private Partnerships Addressing Access to Pharmaceuticals in Low and Middle Income Countries: Zambia
Themes: Tools for enhancing health equity
Authors: Auton, Martin; Dlamini, Qhing Qhing; Lush, Louisiana; Nkandu, Patrick
Keywords: access, collaboration, drugs, impact, low- and middle-income countries, operational issues, pharmaceuticals, poverty, Zambia
Year: 2004 Pages: 60
Abstract:
The UK Department for International Development (DFID) funded the Initiative for Public Private Partnership for Health (IPPPH) to conduct a study in Zambia to assess the health and health systems impact of public-private partnerships (PPPs) for improving access to pharmaceuticals in relation to tropical diseases and HIV / AIDS and prevention and treatment of opportunistic infections. The specific remit of this study was to examine issues of ownership, integration, coordination, implementation and impact, with a particular focus on the unique strengths and problems of these access PPPs as distinct from other comparable programmes where drugs are competitively procured.
ISBN: 2-940286-22-1
open this document and view its contentView the PDF document
Title: Impact of Public-Private Partnerships Addressing Access to Pharmaceuticals in Selected Low and Middle Income Countries: A Synthesis Report from Studies in Botswana, Sri Lanka, Uganda and Zambia
Themes: Tools for enhancing health equity
Authors: Caines, Karen; Lush, Louisiana
Keywords: access, Botswana, collaboration, drugs, impact, low- and middle-income countries, pharmaceuticals, Sri Lanka, Uganda, Zambia
Year: 2004 Pages: 57
Abstract:
This report provides an overview, with general conclusions and recommendations from a series of studies of drug access programmes in selected countries, namely, Uganda the pilot country) plus Botswana, Sri Lanka and Zambia. The studies were initiated by the Initiative on Public-Private Partnerships for Health (IPPPH), supported principally by the UK Department for International Development, and undertaken in association with the Institute for Health Sector Development based in London.
These studies add considerably to the previous limited evidence base on the impacts of such programmes at country level.
ISBN: 2-940286-21-3
open this document and view its contentView the PDF document
Title: Impact of Public-Private Partnerships Addressing Access to Pharmaceuticals in Low Income Countries: Uganda Pilot Study
Themes: Tools for enhancing health equity
Authors: Bataringaya, Julie; Caines, Karen; Lush, Louisiana; Murindwa, Grace; N'jie, Hatib
Keywords: access, collaboration, drugs, low-income countries, operational issues, pharmaceuticals, pilot study, poverty, Uganda
Year: 2003 Pages: 104
Abstract:
The UK Department for International Development (DFID) funded the Initiative on Public-Private Partnership for Health (IPPPH) to conduct a pilot study in Uganda to assess the health systems impact of public-private partnerships (PPPs) for improving access to pharmaceuticals in relation to leprosy, lymphatic filariasis, onchocerciasis, sleeping sickness, and HIV /AIDS. The specific remit of this study was to examine issues of ownership, integration, coordination, implementation and impact, with a particular focus on the unique strengths and problems of these access PPPs as distinct from other comparable programmes where drugs are competitively procured.
ISBN: 2-94 0286-10-8
View the PDF document
Title: Innovating for the Heatlth Of All
Year: 2009 Pages:20
[en] [es]
View the PDF document
Title: Innovating for the Health of All: Global Forum Update on Research for Health, Volume 6
Year: 2009 Pages:134
Authors: Gill Samuels, Charles A Gardner, José Ramón Balaguer Cabrera, Nestor Marimón Torres, Evelyn Martínez Cruz, Agustin Lage, Ismael Clark Arxer, Gene Falk, Julia Coyner Robinson, Cynthia Schweer, Bart J Weetjens, Georgies Mgode, B Witkind Davis, Christophe L Cox, Negussia W Beyene, Liza Kimbo, Chorh Chuan Tan, François Bonnici, Mirjam Schöning, Amrita Palriwala, Aarthi Rao, Usha R Balakrishnan, Tembeka Mpako-Ntusi, Ntobeko BA Ntusi, Sylvia de Haan, Samuel Anya, Ayo Palmer, Paul Bloch, Roberto Tapia-Conyer, Rodrigo Saucedo, Satoshi Omura, Andy Crump, Toshihiko Hasegawa, Mubashar Sheikh, Sigrun Møgedal, Mary Moran, Javier Guzman, Klara Henderson, Alina McDonald, Brenda Omune, Catherine M Michaud, Anthony D So, Joanna Chataway, Rebecca Hanlin, Louis Muraguri, Watu Wamae, Vijay K Vijayaraghavan, Charles W Wessner, Michel D Kazatchkine, Rifat Atun, Mary Ann Lansang, Tania Cernuschi, Cheri Grace, Margaret Kyle, Raghunath Anant Mashelkar, Bhushan Patwardhan, Shiladitya Sengupta
Keywords: Public Health Care; Entrepreneurship; Pharmaceutical Industry; Medical Technology; Medical Patents; Medicines; International Cooperation; Innovation Financing; Innovation; Civil Society; Tuberculosis; HIV / AIDS; Africa; Japan; Singapore; Brazil; Philanthropy; Public-Private Partnerships
[en]
open this document and view its contentView the PDF document
Title: Interventions against Antimicrobial Resistance
Themes: Tools for enhancing health equity
Authors: Smith, Richard D.
Keywords: antimicrobial resistance (AMR), control, costs, effectiveness, methodologies, modeling, prevent, research agenda, strategies
Year: 2001 Pages: xii+158
Abstract:
Antimicrobial resistance (AMR) is one of the biggest challenges facing global public health at the beginning of the third millennium. However, there is little accurate information concerning many aspects of AMR.
[fr]
ISBN: 2-940286-06-X
 Back to top
© Global Forum for Health Research 2008